gastric cancer
Conditions
Interventions
Helicobacter pylori antibody (baseline, 1 time)
Serum pepsinogen (baseline, 1 time)
Sponsors
Japan Agency for Medical Research and Development
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)50 years to 69 years at baseline screening for gastric cancer 2)Obtaining informed consent for participation in research screening
Exclusion criteria
Exclusion criteria: 1) having serious diseases 2) having any treatments for cancers 3) having any gastric disease 4) participants in the preceding study in Niigata city
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cumulative incidence of gastric cancer | — |
Secondary
| Measure | Time frame |
|---|---|
| Sensitivity, specificity, rate of adverse effects | — |
Countries
Japan
Contacts
Public ContactChisato Hamashima
Teikyo University Faculty of Medical Techmology
Outcome results
None listed